-
-
-
-
-
-
-
G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August
-
-
-
-
-
-
-
BTIG Assumes G1 Therapeutics (GTHX) at Buy
-
-
-
-
-
-
-
G1 Therapeutics (GTHX) PT Raised to $48 at BTIG; 'Phase 2a SCLC Data a Strong Start for Trilaciclib'
-
9,666 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

